The inwardly rectifying K+ channel KIR7.1 controls uterine excitability throughout pregnancy

• DOI: 10.15252/emmm.201403944
• Publication Date: 2014-07-24T02:31:41Z
• Authors: Conor McCloskey; Cara Rada; Elizabeth Bailey; Samantha McCavera; Hugo A van den Berg; Jolene Atia; David A Rand; Anatoly Shmygol; Yi‐Wah Chan; Siobhan Quenby; Jan J Brosens; Manu Vatish; Jie Zhang; Jerod S Denton; Michael J Taggart; Catherine Kettleb...; David Tickle; Jeff Jerman; Paul Wright; Timothy Dale; Srinivasan Kanumilli; Derek J Trezise; Steve Thornton; Pamela Brown; Roberto Catalano; Nan Lin; Sarah K England; Andrew M Blanks
• Keywords: 0301 basic medicine; Medicine (General); Patch-Clamp Techniques; QH426-470; In Vitro Techniques; Cell Line; Membrane Potentials; Mice; Uterine Contraction; 03 medical and health sciences; R5-920; Cricetulus; Pregnancy; Cricetinae; Genetics; Animals; Humans; Potassium Channels, Inwardly Rectifying; parturition; Research Articles; Labor, Obstetric; uterus; myometrium; potassium channels; Immunohistochemistry; 3. Good health; Mice, Inbred C57BL; Gene Knockdown Techniques; Female; pregnancy; RG

AbstractAbnormal uterine activity in pregnancy causes a range of important clinical disorders, including preterm birth, dysfunctional labour and post‐partum haemorrhage. Uterine contractile patterns are controlled by the generation of complex electrical signals at the myometrial smooth muscle plasma membrane. To identify novel targets to treat conditions associated with uterine dysfunction, we undertook a genome‐wide screen of potassium channels that are enriched in myometrial smooth muscle. Computational modelling identified Kir7.1 as potentially important in regulating uterine excitability during pregnancy. We demonstrate Kir7.1 current hyper‐polarizes uterine myocytes and promotes quiescence during gestation. Labour is associated with a decline, but not loss, of Kir7.1 expression. Knockdown of Kir7.1 by lentiviral expression of miRNA was sufficient to increase uterine contractile force and duration significantly. Conversely, overexpression of Kir7.1 inhibited uterine contractility. Finally, we demonstrate that the Kir7.1 inhibitor VU590 as well as novel derivative compounds induces profound, long‐lasting contractions in mouse and human myometrium; the activity of these inhibitors exceeds that of other uterotonic drugs. We conclude Kir7.1 regulates the transition from quiescence to contractions in the pregnant uterus and may be a target for therapies to control uterine contractility.